Life sciences news
-
Pathomation announces new release of the “My Pathomation” cloud platform for digital pathology
Friday September 2nd 2022
Read more
-
reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration
Wednesday August 31st 2022
Read more
-
Autoimmune disorders increase risk of cardiovascular disease
Saturday August 27th 2022
Read more
-
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
Wednesday June 22nd 2022
Read more
-
Pathomation announces CE-IVD mark for clinical diagnostic use of vendor neutral PMA.core software
Tuesday May 31st 2022
Read more
-
CureVac partners with myNEO to identify novel antigen targets for mRNA-based cancer vaccine development
Wednesday May 25th 2022
Read more
-
Ziphius Vaccines and Ghent University publish promising data from self-amplifying RNA platform in Molecular Therapy
Friday May 6th 2022
Read more
-
New study led by Memorial Sloan Kettering Cancer Center (NY, US) shows Idylla™ GeneFusion Assay enables more rapid screening of targetable fusions compared to routine methods
Wednesday May 4th 2022
Read more
-
Your news here?
-
reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a
Tuesday May 3rd 2022
Read more
-
Kantify and I-Stem Use Artificial Intelligence to discover a promising therapy against a rare disease
Wednesday April 27th 2022
Read more
-
Mithra CDMO announces collaboration with MedinCell for the development of injectable products for Malaria and transplant rejection
Tuesday April 26th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator